Details of the Drug

General Information of Drug (ID: DMUGRS8)

Drug Name

Ioforminol

Synonyms

AN-113111; GE-145

Indication

Disease Entry	ICD 11	Status	REF
Pulmonary embolism	BB00	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C33H40I6N6O15
Canonical SMILES: C(C(CO)O)NC(=O)C1=C(C(=C(C(=C1I)N(CC(CN(C=O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)O)C=O)I)C(=O)NCC(CO)O)I
InChI: 1S/C33H40I6N6O15/c34-22-18(30(57)40-1-13(52)7-46)24(36)28(25(37)19(22)31(58)41-2-14(53)8-47)44(11-50)5-17(56)6-45(12-51)29-26(38)20(32(59)42-3-15(54)9-48)23(35)21(27(29)39)33(60)43-4-16(55)10-49/h11-17,46-49,52-56H,1-10H2,(H,40,57)(H,41,58)(H,42,59)(H,43,60)
InChIKey: BFVVDRUCXCIALU-UHFFFAOYSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01252810) Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure. U.S. National Institutes of Health.